Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)

Summary

This trial is conducted in Europe. The aim of this trial is to evaluate the clinical efficacy of a single dose of NNC0142-0002 administered to subjects with active rheumatoid arthritis (RA).

Timeline

Start

2010-08

Primary completion

2012-04

Completion

2012-04

Outcome

Missed primary endpoint

registry analysis (superiority or other test); 4.0 mg/kg vs Placebo; p = 0.9334; Treatment difference -0.02 (95% CI -0.54 to 0.50) NCT01181050 ↗

Drugs

Indications